COVID-19's Impact on Cancer Data

Presented by

Dr. Serban Negoita, Dr. Oguzhan Alagoz, Karen Schmidt, Vontyna Smith

About this talk

The COVID-19 pandemic has had a significant impact on all facets of cancer care, including a reduction in screening exams, delaying diagnoses and treatment as well as halting clinical trials. As care providers work tirelessly to ensure that patients continue to receive essential treatment while minimizing exposure to the virus, what can we expect to learn from the data? In this episode, Dr. Serban Negoita, Chief of the Data Quality. Analysis and Interpretation Branch at the National Cancer Institute, Dr. Oguzhan Alagoz, Breast CISNET modeler from University of Wisconsin-Madison, and Karen Schmidt, CTR, vice president of CHAMPS Oncology, will discuss what we can learn from this pandemic, the long term effects on survival rates and the implications on cancer statistics.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (19)
Subscribers (970)
The Healthcare Leadership Series, presented by The Center for Health Affairs and CHAMPS, provides the opportunity to hear relevant insights, lessons and perspectives from global healthcare experts. These healthcare leaders are among those tasked with charting the path forward as the world continues to navigate an everchanging healthcare landscape in the wake of the COVID-19 pandemic, bringing an invaluable wealth of industry knowledge and experience to the discussion. Join us for a range of conversation topics impacting healthcare and hospitals, including COVID-19 and the ongoing vaccine rollout, value-based care, population health and health disparities, supply chain, cybersecurity, healthcare policy and more.